Participants 692 855 6
clinical trial was conducted on epistaxis patients whose nasal hemorrhage persisted despite adequate nasal packing by the otolaryngology-head and neck surgery team
Participants 872 961 3
patients are given a trial of intranasal FloSeal hemostatic matrix to abort the epistaxis
Participants 1083 1197 6
success in 80% of patients with persistent epistaxis, who would have otherwise been taken to the operating theatre
Participants 1268 1375 5
enrolled patients with persistent nasal hemorrhage were adequately managed with the hemostatic matrix alone
